208 related articles for article (PubMed ID: 24674923)
1. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.
Katsenos CS; Antonopoulou AN; Apostolidou EN; Ioakeimidou A; Kalpakou GT; Papanikolaou MN; Pistiki AC; Mpalla MC; Paraschos MD; Patrani MA; Pratikaki ME; Retsas TA; Savva AA; Vassiliagkou SD; Lekkou AA; Dimopoulou I; Routsi C; Mandragos KE;
Crit Care Med; 2014 Jul; 42(7):1651-7. PubMed ID: 24674923
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
3. Comparing hydrocortisone and methylprednisolone in patients with septic shock.
Yu TJ; Liu YC; Yu CC; Tseng JC; Hua CC; Wu HP
Adv Ther; 2009 Jul; 26(7):728-35. PubMed ID: 19629409
[TBL] [Abstract][Full Text] [Related]
4. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
5. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
7. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
Hu B; Li JG; Liang H; Zhou Q; Yu Z; Li L; Luo Y; Liu C; Gan Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):529-31. PubMed ID: 19751560
[TBL] [Abstract][Full Text] [Related]
8. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.
Fernández J; Escorsell A; Zabalza M; Felipe V; Navasa M; Mas A; Lacy AM; Ginès P; Arroyo V
Hepatology; 2006 Nov; 44(5):1288-95. PubMed ID: 17058239
[TBL] [Abstract][Full Text] [Related]
9. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
[TBL] [Abstract][Full Text] [Related]
10. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
Mussack T; Briegel J; Schelling G; Jochum M
Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
[TBL] [Abstract][Full Text] [Related]
11. Effects of Increasing Hydrocortisone to 300 mg Per Day in the Treatment of Septic Shock: a Pilot Study.
Hyvernat H; Barel R; Gentilhomme A; Césari-Giordani JF; Freche A; Kaidomar M; Goubaux B; Pradier C; Dellamonica J; Bernardin G
Shock; 2016 Nov; 46(5):498-505. PubMed ID: 27405061
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting.
Ragoonanan D; Allen B; Cannon C; Rottman-Pietrzak K; Bello A
Ann Pharmacother; 2022 Mar; 56(3):264-270. PubMed ID: 34109850
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses.
Briegel J; Jochum M; Gippner-Steppert C; Thiel M
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S70-4. PubMed ID: 11251036
[TBL] [Abstract][Full Text] [Related]
14. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
Oppert M; Schindler R; Husung C; Offermann K; Gräf KJ; Boenisch O; Barckow D; Frei U; Eckardt KU
Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
[TBL] [Abstract][Full Text] [Related]
15. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
Valoor HT; Singhi S; Jayashree M
Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Initiation Timing of Hydrocortisone in Adult Patients With Septic Shock.
Sacha GL; Chen AY; Palm NM; Duggal A
Shock; 2021 Apr; 55(4):488-494. PubMed ID: 32890314
[TBL] [Abstract][Full Text] [Related]
17. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock.
Bellissant E; Annane D
Clin Pharmacol Ther; 2000 Sep; 68(3):293-303. PubMed ID: 11014411
[TBL] [Abstract][Full Text] [Related]
19. Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock.
Maxime V; Fitting C; Annane D; Cavaillon JM
J Infect Dis; 2005 Jan; 191(1):138-44. PubMed ID: 15593015
[TBL] [Abstract][Full Text] [Related]
20. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
Mussack T; Briegel J; Schelling G; Jochum M
Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
